Lemu, Finland

Anna Cvrljevic



 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2016-2018

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Anna Cvrljevic

Introduction

Anna Cvrljevic is a prominent inventor based in Lemu, Finland, recognized for her significant contributions in the field of pharmaceuticals. With a total of two patents to her name, Anna has focused her research on innovative treatments for hyperproliferative disorders, particularly targeting cancer therapies. Her work has opened new avenues in the fight against cancer, providing hope for more effective treatment options.

Latest Patents

Anna Cvrljevic’s latest patents revolve around the use of a CIP2A silencing agent. The first patent details a pharmaceutical combination intended for use in treating hyperproliferative disorders, focusing on cases where there is impaired p53 function. The invention is predicated on the discovery that silencing the CIP2A (KIAA1524) gene enhances the sensitivity of cancer cells to apoptosis-inducing effects of specific small molecule chemotherapeutic agents. This groundbreaking approach not only offers a novel combination therapy but also presents a method for selecting cancer treatment based on the expression and protein activity levels of CIP2A and p53 obtained from patient samples.

Career Highlights

Anna is currently affiliated with the University of Turku (Turun Yliopisto), where she continues to advance her research and explore innovative solutions in oncology. Her academic and research efforts contribute substantially to the understanding of cancer biology and the development of targeted therapies.

Collaborations

Throughout her career, Anna has collaborated with Jukka Westermarck, a notable figure in cancer research. Their joint efforts reflect a commitment to exploring groundbreaking strategies for cancer treatment, leveraging their expertise to improve patient outcomes.

Conclusion

Anna Cvrljevic stands out as a vital contributor to the field of pharmaceutical sciences. Her innovative patents and collaborations signify a persistent drive to enhance cancer therapies, establishing her as an influential inventor in her domain. As her research progresses, Anna's work is poised to make a lasting impact in the fight against cancer, inspiring future innovations in treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…